Paris, December 8, 2017 – Discngine, a French software company dedicated to the R & D departments of life sciences companies, is opening its capital with the arrival of Extens, an investment vehicle 100% dedicated to e-health.
Based in Paris, Discngine develops software solutions that offer high-performance data acquisition and analysis tools, particularly for the molecular research needs of pharmaceutical companies.
“Thanks to this investment, our teams will be able to concretise the industrialization projects of our high value-added technologies and launch them commercially via a SaaS (Software-as-a-Service) offer accessible to researchers all over the world” explains Eric Le Roux, founder and CEO of Discngine. “Discngine now has the means to accelerate its development internationally”
Arnaud Houette, managing partner of Extens, is delighted: “We are delighted to accompany Discngine. The company has developed a state-of-the-art technology platform to increase the efficiency of finding ‘winning’ molecules. The challenge is not only financial, but above all medical. Extens is at the heart of its strategy: identifying young French SMEs in e-health, promising technologies, helping them accelerate their development and thus contribute to an improvement of our health system. ”
About Discngine (www.discngine.com):
The company Discngine, which employs 35 people in Paris, is a software company specializing in applications for the research services of life sciences companies, more specifically for work on active molecules.
It was created in 2004 by two of Pfizerafin’s research alumni to develop software that increases the effectiveness of life science research.
Her clients include world leaders in the pharmaceutical, cosmetics and agrochemical industries.
The Company’s offer has historically been developed around custom software, then licenses for software components and finally licenses for business solutions. The challenge is to move from selling hours to selling licenses (catalog products in SaaS / Cloud mode).
About Extens (www.extens.fr):
Extens is an investment vehicle dedicated to the e-health sector. Extens invests € 1 to € 7 million in profitable or close-to-mid-size companies with sales of between € 1 million and € 20 million. Its core target: hospital software, business software for healthcare professionals and home and mobility care solutions.
Discngine is his fifth investment (in portfolio) and the third this year, after Snal (Albus) and Must Computer.